• Clodronate Liposomes: Decoding Tumor Macrophage Immunity

  2026-06-29

  Discover how Clodronate Liposomes enable precise in vivo macrophage depletion and unlock new insights into immunotherapy resistance. This article uniquely integrates mechanistic advances and translational assay guidance for immunological research.

• LY2109761: Advancing TGF-β Dual Inhibition in Translational

  2026-06-29

  This article delivers a forward-thinking analysis of LY2109761, a dual TGF-β receptor type I and II kinase inhibitor, for translational researchers navigating the complexities of TGF-β signaling in cancer and fibrosis. Bridging mechanistic insight with strategic guidance, it contextualizes recent findings in cell cycle regulation, highlights APExBIO’s product rigor, and offers actionable parameters and outlooks for the next generation of disease modeling and targeted intervention.

• Mdivi-1: Strategic Leadership in Mitochondrial Fission Inhib

  2026-06-28

  This thought-leadership article leverages cutting-edge mechanistic insights and strategic guidance to empower translational researchers investigating mitochondrial dynamics, apoptosis, and neuroprotection. By integrating evidence from key studies and scenario-driven best practices, we explore how APExBIO’s Mdivi-1 enables robust, reproducible experiments and paves the way for disease model innovation.

• Berberine Modulates RXRα/PPARγ/NEDD4 to Limit Inflammation i

  2026-06-27

  This study clarifies how berberine inhibits senescence-associated secretory phenotype (SASP)-driven inflammation in atherosclerosis by modulating the RXRα/PPARγ/NEDD4 pathway. The work provides mechanistic insight into how targeting this axis could suppress inflammatory aging in vascular disease, informing future research and therapeutic strategies.

• Energy Deficiency, ATG4B, and DNA Repair in AML Progression

  2026-06-26

  This study uncovers a mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia. The key innovation lies in identifying ATG4B nuclear translocation as a suppressor of PRMT1-mediated DNA repair, promoting leukemic evolution, and suggesting new intervention strategies targeting this axis.

• Resiniferatoxin (RTX): Optimizing TRPV1 Silencing for Pain M

  2026-06-26

  Resiniferatoxin’s unparalleled selectivity and potency as a TRPV1 agonist are redefining experimental pain and neurogenic inflammation research. This article delivers actionable protocols, troubleshooting expertise, and workflow innovations that harness RTX’s unique mechanism for both bench and translational applications.

• Advancing Amplex Red-Based Screening of CYP119 P450 Mutants

  2026-06-25

  This study introduces an improved Amplex Red peroxidation assay for efficient screening of hydrogen peroxide-dependent activity in cytochrome P450 variants, enabling identification of a novel, high-activity CYP119 mutant. The findings expand biocatalyst engineering strategies for oxidative biotransformations and offer robust assay protocols for redox enzyme research.

• Necrostatin 2 (Nec-2): Advanced Workflows for Necroptosis In

  2026-06-25

  Necrostatin 2 (Nec-2) enables precise, nanomolar-range RIPK2 inhibition for dissecting necroptosis in immune and tissue damage models. This guide delivers actionable protocol parameters, troubleshooting strategies, and highlights from ground-breaking research, making Nec-2 from APExBIO a pivotal asset for translational and mechanistic cell death studies.

• Capsaicin (E)-Capsaicin: TRPV1 Activation & KDM1A Inhibition

  2026-06-24

  Capsaicin, a vanillamide compound, is a dual modulator: it activates the TRPV1 ion channel and inhibits lysine-specific demethylase 1A (KDM1A/LSD1). Extensive evidence supports its use in pain, inflammation, and gastric cancer research. APExBIO's Capsaicin (SKU C6366) offers validated, reproducible performance for precise experimental workflows.

• Budesonide Permeability Profiling: Innovations in In Vitro P

  2026-06-23

  Explore Budesonide as a model anti-inflammatory corticosteroid in advanced pulmonary permeability profiling. This article reveals how new biomimetic chromatographic methods are transforming respiratory disease research, offering insights beyond standard asthma inflammation models.

• Myriocin: Strategic Sphingolipid Inhibition for Translationa

  2026-06-23

  This article delivers a thought-leadership analysis of Myriocin as a selective serine palmitoyltransferase inhibitor, highlighting mechanistic insights, translational strategies, and evidence-based guidance for cancer, metabolic, and immunology researchers. Drawing from recent preclinical breakthroughs, including AMPK-PGC1α pathway modulation and metabolic homeostasis restoration, the discussion offers a roadmap for leveraging Myriocin in advanced sphingolipid metabolism research and beyond.

• Nanoparticle-Enhanced Scaffolds Modulate JAK2/STAT3 for Bone

  2026-06-22

  This study introduces dual-responsive, magneto-piezoelectric nanoparticles embedded in 3D-printed scaffolds to disrupt bacterial biofilms and activate the JAK2/STAT3 pathway in Icam1+ macrophages, driving effective regeneration of infectious bone defects. The findings highlight a new immunomodulatory strategy that couples infection control with bone healing via precise molecular targeting.

• Olsalazine Sodium: Applied Workflows for Cancer and Inflamma

  2026-06-22

  Olsalazine Sodium, a mesalamine dimer, is redefining experimental approaches in inflammation and colorectal cancer research. This guide details advanced workflow enhancements, troubleshooting strategies, and cross-domain insights inspired by the latest xenobiotic transport studies.

• Optimizing Cell Tracking with DiR (DiIC 18 (7)) Membrane Pro

  2026-06-21

  DiR (DiIC 18 (7)) revolutionizes long-term, near-infrared membrane labeling, enabling precise tracking of live and fixed cells, as well as extracellular vesicles, in complex in vivo contexts. Its integration into advanced 'Engage & Evasion' workflows maximizes imaging sensitivity and therapeutic impact for regenerative studies.

• Isoproterenol Sulfate Dihydrate in Advanced Pacemaker Modeli

  2026-06-20

  Isoproterenol sulfate dihydrate empowers researchers to dissect beta-adrenergic signaling in human cardiac assembloid systems, enabling precise modulation of pacemaker maturation and neuro-cardiac interactions. This article unpacks experimental workflows, protocol refinements, and troubleshooting strategies to maximize reproducibility and data quality in cardiovascular research.

436 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page